相关实验视频
Updated: Mar 13, 2026

10:43
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
4.2K
尼帕尔1驱动一种代谢-表观遗传反循环,以促进食道癌中的乳酸介导免疫逃避
Ri-Xin Chen1,2,3, Xiao-Dan Ma2, Shui-Dan Xu2,4
1Department of Thoracic Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|March 12, 2026
概括
一个涉及NIPAL1,HCK和乳酸的新型代谢-表观遗传电路增强了食道状细胞癌 (ESCC) 的生长和免疫逃避. 针对这一循环可能会改善ESCC患者的免疫疗法疗效.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 免疫学 免疫学 免疫学
背景情况:
- 代谢重编程对于癌症的进展和免疫规避至关重要.
- 食道状细胞癌 (ESCC) 呈现出推动瘤生长的代谢变化.
- 了解代谢-表观遗传交叉是开发新型癌症疗法的关键.
研究的目的:
- 在ESCC中识别和描述NIPAL1驱动的代谢-表观遗传电路.
- 阐明这种电路促进瘤生长和免疫抑制的机制.
- 评估ESCC中针对该电路的治疗潜力.
主要方法:
- 研究了NIPAL1在ESCC代谢和免疫逃避中的作用.
- 使用生物化学测试来确定NIPAL1,HCK和LDHA之间的相互作用.
- 评估了乳酸积累对基因激素乳酸化 (H3K18la) 和基因表达的影响.
- 研究了HCK和p300的药理抑制对瘤免疫力和抗PD-1治疗反应的影响.
- 与ESCC患者免疫检查点阻塞的临床反应相关的分子标志物.
主要成果:
- 确定了一个NIPAL1-HCK-p-LDHA-乳酸盐-p300-H3K18la信号循环,该循环增强ESCC中的糖解和乳酸盐生产.
- 证明这种循环通过损害CD8+T细胞功能来促进免疫逃生,独立于NIPAL1的运输活性.
- 表明抑制HCK或p300会破坏循环,恢复抗瘤免疫力,并使瘤对抗PD-1疗法的敏感.
- 发现NIPAL1,p-LDHA (Y10) 和H3K18la表达水平与ESCC中免疫检查点阻塞的反应相关.
结论:
- 发现了一种新的代谢-表观遗传电路,将瘤代谢与ESCC中的免疫调节相结合.
- 这个NIPAL1-HCK-H3K18la轴代表了一个有前途的治疗标,用于提高ESCC的免疫疗法疗效.
- 针对这种循环提供了一种潜在的策略,以克服免疫逃避并改善ESCC患者的治疗结果.
相关概念视频
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Epigenetic Regulation
4.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.1K
Epigenetic Regulation
34.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.1K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K